Find RP1 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: (rp)-camps, Cyclic apt, Rp-camps, Adenosine-3',5'-cyclic phosphorothioate, 23645-17-2, (sp)-camps
Molecular Formula
C10H12N5O5PS
Molecular Weight
345.27  g/mol
InChI Key
SMPNJFHAPJOHPP-JOILOJCLSA-N

RP1
1 2D Structure

RP1

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
2.1.2 InChI
InChI=1S/C10H12N5O5PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(19-10)1-18-21(17,22)20-7/h2-4,6-7,10,16H,1H2,(H,17,22)(H2,11,12,13)/t4-,6-,7-,10-,21?/m1/s1
2.1.3 InChI Key
SMPNJFHAPJOHPP-JOILOJCLSA-N
2.1.4 Canonical SMILES
C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=S)(O1)O
2.1.5 Isomeric SMILES
C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=S)(O1)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. (r)-p-camps

2. (rp)-camps

3. 3,5'-camps

4. Adenosine 3',5'-cyclic Monophosphorothioate

5. Adenosine 3',5'-monothionophosphate

6. Adenosine-3',5'-cyclic Phosphorothioate

7. Adenosine-3',5'-monophosphorothioate

8. Cyclic Adenosine 3,'5'-phosphorothioate

9. Cyclic Apt

10. P-adenosine 3',5'-cyclic Phosphorothiate

11. R(p)-camps

12. Rp-camp-s

13. Sp-camp-s

2.2.2 Depositor-Supplied Synonyms

1. (rp)-camps

2. Cyclic Apt

3. Rp-camps

4. Adenosine-3',5'-cyclic Phosphorothioate

5. 23645-17-2

6. (sp)-camps

7. Chebi:84615

8. Chebi:84622

9. Adenosine-3',5'-cyclic -monophosphorothioate

10. 71774-13-5

11. Rp-camp-s

12. Sp-camp-s

13. (r)-p-camps

14. 3,5'-camps

15. Sp-adenosine-3',5'-cyclic-monophosphorothioate

16. Rp-adenosine 3',5'-cyclic Monophosphorothioate, Sodium Salt

17. R(p)-camps

18. Adenosine 3',5'-monothionophosphate

19. Adenosine-3',5'-monophosphorothioate

20. 6-(6-amino-purin-9-yl)-2-thioxo-tetrahydro-2-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol

21. Cyclic Adenosine 3,'5'-phosphorothioate

22. P-adenosine 3',5'-cyclic Phosphorothiate

23. Adenosine 3',5'-cyclic Monophosphorothioate

24. 73208-40-9

25. Adenosine, Cyclic 3',5'-(hydrogen Phosphorothioate)

26. Gtpl5262

27. Schembl4159569

28. Chembl1235719

29. Chembl1236010

30. Schembl22370431

31. Dtxsid20178316

32. Chebi:191063

33. Adenosine 3',5'-thiophosphoric Acid

34. Db01790

35. Hy-100530a

36. Hy-100530b

37. Ncgc00182722-01

38. Ncgc00485585-01

39. (4ar,6r,7r,7as)-6-(6-aminopurin-9-yl)-2-hydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol

40. Cs-0019676

41. Cs-0107084

42. (rp)-adenosine-3',5'-cyclic Monophosphorothioate

43. (sp)-adenosine-3',5'-cyclic Monophosphorothioate

44. Q27088619

45. Q27157921

46. Rp-adenosine-3',5'-cyclic-monophosphorothioate

47. Adenosine-3',5'-cyclic Monophosphorothioate, Rp-isomer

48. Adenosine-3',5'-cyclic Monophosphorothioate, Sp-isomer

49. Adenosine, Cyclic 3',5'-[hydrogen [p(s)]-phosphorothioate]

50. Adenosine- 3', 5'- Cyclic Monophosphorothioate, Rp- Isomer

51. (2r,4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)-7-hydroxy-2-sulfanyltetrahydro-2h,4h-2lambda(5)-furo[3,2-d][1,3,2]dioxaphosphinin-2-one

52. (2r,4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-sulfide

53. (2s,4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)-7-hydroxy-2-sulfanyltetrahydro-2h,4h-2lambda(5)-furo[3,2-d][1,3,2]dioxaphosphinin-2-one

54. (2s,4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-sulfide

55. (4ar,6r,7r,7as)-6-(6-aminopurin-9-yl)-2-hydroxy-2-sulanylidene-4a,6,7,7a-tetrahydro-4h-uro[3,2-d][1,3,2]dioxaphosphinin-7-ol

56. Rp1

2.3 Create Date
2006-07-03
3 Chemical and Physical Properties
Molecular Weight 345.27 g/mol
Molecular Formula C10H12N5O5PS
XLogP3-0.8
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count10
Rotatable Bond Count1
Exact Mass345.02967667 g/mol
Monoisotopic Mass345.02967667 g/mol
Topological Polar Surface Area170 Ų
Heavy Atom Count22
Formal Charge0
Complexity502
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Protein Kinase Inhibitors

Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty